Climb Bio Inc. (CLYM)
NASDAQ: CLYM
· Real-Time Price · USD
1.90
0.18 (10.47%)
At close: Aug 15, 2025, 2:52 PM
10.47% (1D)
| Bid | 1.67 |
| Market Cap | 128.41M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -92.98M |
| EPS (ttm) | -0.02 |
| PE Ratio (ttm) | -94.75 |
| Forward PE | -1.78 |
| Analyst | Buy |
| Ask | 2.1 |
| Volume | 838,685 |
| Avg. Volume (20D) | 371,829 |
| Open | 1.73 |
| Previous Close | 1.72 |
| Day's Range | 1.73 - 1.92 |
| 52-Week Range | 1.05 - 8.79 |
| Beta | -0.10 |
About CLYM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLYM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLYM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+12.1%
Climb Bio shares are trading higher after Oppenhei...
Unlock content with
Pro Subscription
9 months ago
+7.12%
Climb Bio shares are trading higher. The company announced it appointed a new chair to its board of directors.